Pluri (PLUR) Non-Current Assets (2011 - 2025)
Pluri (PLUR) reported Non-Current Assets of $16.8 million for Q4 2025, up 97.76% year-over-year from $8.5 million in Q4 2024, and little changed quarter-over-quarter from $16.8 million in Q3 2025.
Pluri (PLUR) Non-Current Assets (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Non-Current Assets data on file, last reported at $16.8 million in Q4 2025.
- Non-Current Assets for Q4 2025 came in at $16.8 million, up 97.76% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.8 million (up 97.76% YoY), and the FY2025 annual result was $16.6 million, up 97.01% from the prior year.
- Non-Current Assets held at $16.8 million in Q4 2025 per PLUR's latest filing, from $16.8 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $29.4 million in Q1 2021 and troughed at $8.4 million in Q3 2024.
- A 5-year average of $13.7 million and a median of $10.0 million in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2021 and 2022: Non-Current Assets surged 464.39% in 2021, then tumbled 60.57% in 2022.
- A 5-year view of Non-Current Assets shows it stood at $21.0 million in 2021, then slumped by 53.46% to $9.8 million in 2022, then slipped by 4.85% to $9.3 million in 2023, then retreated by 8.82% to $8.5 million in 2024, then soared by 97.76% to $16.8 million in 2025.
- Business Quant data shows PLUR's Non-Current Assets at $16.8 million in Q4 2025, $16.8 million in Q3 2025, and $16.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 39.71 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 16.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.79 Mn |
| Sep 30, 2025 | 16.75 Mn |
| Jun 30, 2025 | 16.59 Mn |
| Mar 31, 2025 | 9.95 Mn |
| Dec 31, 2024 | 8.49 Mn |
| Sep 30, 2024 | 8.41 Mn |
| Jun 30, 2024 | 8.42 Mn |
| Mar 31, 2024 | 9.02 Mn |
| Dec 31, 2023 | 9.31 Mn |
| Sep 30, 2023 | 9.28 Mn |
| Jun 30, 2023 | 9.39 Mn |
| Mar 31, 2023 | 9.55 Mn |
| Dec 31, 2022 | 9.79 Mn |
| Sep 30, 2022 | 10.03 Mn |
| Jun 30, 2022 | 10.32 Mn |
| Mar 31, 2022 | 14.81 Mn |
| Dec 31, 2021 | 21.03 Mn |
| Sep 30, 2021 | 20.92 Mn |
| Jun 30, 2021 | 26.17 Mn |
| Mar 31, 2021 | 29.35 Mn |